- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05178446
GERD After Sleeve Gastrectomy
The New Onset of GERD After Sleeve Gastrectomy: a Systematic Review
The main adverse effect is gastroesophageal reflux disease (GERD), with concern on the development of Barrett's esophagus and esophageal adenocarcinoma in the long term. However, the relationship between SG and GERD is complex. The aim of this study is to systematically evaluate all published data existing in the literature to evaluate the effect of sleeve gastrectomy on GERD, esophagitis, BE in order to clarify the long-term clinical sequelae of this procedure.
This systematic review was conducted in accordance with the guidelines for Preferred Reporting Items for Systematic Review and Meta-analyzes (PRISMA).
Published studies that contained outcome data for primary sleeve gastrectomy associated with the primary and secondary outcomes listed below were included.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Foggia, Italy, 71122
- University of Foggia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients underwent to sleeve gastrectomy with reflux symptoms
Exclusion Criteria:
- Patients underwent to other bariatric procedures
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastroesophageal reflux disease after bariatric surgery
Time Frame: from 2014 to 2018
|
Number of patients underwent sleeve gastrectomy with GERD
|
from 2014 to 2018
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nicola Tartaglia, University of Foggia
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on GERD
-
Baylor Research InstituteRecruiting
-
Ohio State UniversityCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalRecruiting
-
Cinclus Pharma Holding ABCompleted
-
Korea United Pharm. Inc.CompletedGERDKorea, Republic of
-
Korea United Pharm. Inc.Completed
-
Chong Kun Dang PharmaceuticalUnknown
-
Turku University HospitalCompleted